Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy Subjects

Garenoxacin (T-3811ME, BMS-284756) is a novel des-F(6) quinolone that has been shown to be effective in vitro against a wide range of clinically important pathogens, including gram-positive and gram-negative aerobes and anaerobes. This study was conducted to evaluate the safety and tolerability of m...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Gajjar, D. A., Bello, A., Ge, Z., Christopher, L., Grasela, D. M.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2003
主題:	Pharmacology
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC161848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12821477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.7.2256-2263.2003
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!